Poland· PL-100121812

Digestiol

A medicinal product containing cynarae herbae extractum siccum, registered in Poland by Poznańskie Zakłady Zielarskie "Herbapol" S.A..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDigestiolATC—REGISTER NO.PL-100121812PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Cynarae herbae extractum siccum
Manufacturer
Poznańskie Zakłady Zielarskie "Herbapol" S.A.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991046613
  • gtin
    05909991046620

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fad7ce7e-12ca-4992-9ae0-7f9a744bebdf
GET /v1/drugs/fad7ce7e-12ca-4992-9ae0-7f9a744bebdf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "170 mg",
  "packaging": "05909991046613 ¦ OTC ¦ 22883\n30 kaps. w blistrze\n05909991046620 ¦ OTC ¦ 22884\n1 poj. 30 kaps.",
  "substance": "Cynarae herbae extractum siccum 170 mg",
  "common_name": "Cynarae herbae extractum siccum",
  "pl_product_id": "100121812",
  "pozwolenie_nr": "10466",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about cynarae herbae extractum siccum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.